Physician profile
Setu Devendra Trivedi
NPI 1295053106
$4,594.11
in general payments reported to CMS, 2019-2025
33 companies · $1,062 in 2025
The $1,062 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.26 · 2021: $18.25 · 2023: $1,981 · 2024: $1,520 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,538 · Travel and Lodging: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.81 |
| Travel and Lodging | $1,024.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,434.67 | 2023 | Venaseal |
| Novartis Pharmaceuticals Corporation | $493.39 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.53 | 2023-2025 | Jardiance |
| Abiomed | $256.18 | 2024-2025 | Impella |
| Abbott Laboratories | $201.20 | 2023-2025 | Diamondback Coronary, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $195.92 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $169.63 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $136.89 | 2023-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.16 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $123.83 | 2019-2024 | Xarelto |
| Pfizer INC. | $117.60 | 2023-2025 | |
| Stryker Corporation | $112.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Angiodynamics, INC. | $111.79 | 2024-2025 | Smart Port Ct, Alphavac |
| Tactile Systems Technology INC | $71.08 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Heartflow, INC. | $68.03 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $65.09 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $61.56 | 2024 | Farxiga |
| Terumo Medical Corporation | $58.86 | 2024 | Glidewire, Glidesheath Slender, Metacross Otw |
| Kestra Medical Technology Services, INC. | $58.15 | 2024-2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $58.09 | 2023-2024 | Rotarexs 6 F X 135 Cm, Fluency Endovascular Stent Graft, Lutonix Drug Coated Balloon |
| Boston Scientific Corporation | $53.95 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Novo Nordisk INC | $45.53 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Chiesi USA, INC. | $43.70 | 2024-2025 | Cleviprex, Kengreal |
| Imperative Care, INC | $42.36 | 2024-2025 | Symphony Catheter |
| Kiniksa Pharmaceuticals International, Plc | $33.80 | 2024 | Arcalyst |
| Teleflex LLC | $29.33 | 2025 | Supercross |
| Cvrx, INC. | $28.68 | 2025 | Barostim Neo System |
| Biotronik INC. | $23.70 | 2024 | Pk Papyrus, Orsiro Mission |
| Acist Medical Systems, INC. | $23.26 | 2024 | |
| Edwards Lifesciences Corporation | $22.16 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $17.47 | 2025 | Verquvo |
| Icu Medical INC | $15.33 | 2024 | Clearguard Hd |
| Cordis US Corp. | $14.41 | 2024 | Saber |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Setu Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.